Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

BERTOLOTTO A;CAPOBIANCO M;AMATO MP;CAPELLO E;CAPRA R;CENTONZE D;DI IOIA M;GALLO A;GRIMALDI L;IMBERTI L;LUGARESI A;MANCINELLI C;MARROSU MG;MOIOLA L;MONTANARI E;ROMANO S;MUSU L;PAOLICELLI D;PATTI F;POZZILLI C;ROSSI S;SALVETTI M;TEDESCHI, Gioacchino;TOLA MR;TROJANO M;ZAFFARONI M;MALUCCHI S.

2014